President Trump Orders Big Pharma to Split MMR Vaccine, Faces Industry Backlash
President Trump has issued an executive order mandating the separation of the measles, mumps, and rubella (MMR) vaccine into three individual shots. This directive has been met with immediate resistance from the pharmaceutical industry and medical organizations. The American Academy of Pediatrics, among others, has criticized the order as dangerous and unscientific. The current MMR vaccine, administered in two doses, is widely regarded as safe and effective. The proposed change would require pharmaceutical companies to develop new vaccines, a process that involves significant investment and lacks scientific justification. The pharmaceutical industry, represented by PhRMA, has publicly opposed the order, emphasizing the potential negative impact on vaccine policy.